ArticleFrontiers in medicine2025
Association of follow-up neutrophil-lymphocyte ratio with postoperative pneumonia in aneurysmal subarachnoid hemorrhage patients after endovascular treatment: a retrospective analysis.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Risk factors for postoperative pneumonia following intracranial aneurysm surgery: a propensity score matching analysis.Perioperative medicine (London, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Research on the relationship between dynamic neutrophil-to-lymphocyte ratio (NLR)-measured at different time points around endovascular treatment-and the occurrence of postoperative pneumonia (POP) in patients with aneurysmal subarachnoid hemorrhage (aSAH) is still relatively scarce. This study aims to explore the association between dynamic NLR and the incidence of POP in patients with aSAH undergoing endovascular therapy. Methods: This study included patients with aSAH who underwent endovascular treatment between January 2019 and April 2023. The follow-up endpoint was the presence of POP at 30 days postoperatively. Logistic regression analysis was conducted using POP as the dependent variable. The NLR was calculated at admission (NLR1), 24 h after endovascular treatment (NLR2), and 3-7 days after endovascular treatment (NLR3). Four prediction models were constructed: Model 1 (variables with Results: Among the 154 patients with aSAH, POP occurred in 101 (65.6%) patients. Higher NLRs at admission [odds ratio (OR) = 1.08; 95% confidence interval (CI): 1.02, 1.16; Conclusion: Follow-up NLR may be associated with POP in patients with aSAH treated endovascularly. Elevated NLR at admission, 24 h postoperatively, and 3-7 days postoperatively correlated with a high risk for POP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.